Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
Development of a Selective Peptide κ-Opioid Receptor Antagonist by Late-Stage Functionalization with Cysteine Staples | Journal of Medicinal Chemistry
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists
The main causes of narcotic addiction (e.g., morphine) and strategies... | Download Scientific Diagram
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
The Neuroscience of Drug Reward and Addiction | Physiological Reviews
Antagonist for the Kappa Opioid Receptor - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
Insights from Preclinical Choice Models on Treating Drug Addiction: Trends in Pharmacological Sciences
Kappa Opioid Signaling at the Crossroads of Chronic Pain and Opioid Addiction | SpringerLink
Kappa opioid receptor in nucleus accumbens regulates depressive-like behaviors following prolonged morphine withdrawal in mice - ScienceDirect
The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library
Pharmaceuticals | Free Full-Text | Biased, Bitopic, Opioid–Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction
Conformational Constraint between Aromatic Residue Side Chains in the “Message” Sequence of the Peptide Arodyn Using Ring Closing Metathesis Results in a Potent and Selective Kappa Opioid Receptor Antagonist | Journal of
The Kappa Opioid Receptor: From Addiction to Depression, and Back | Semantic Scholar
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
A Role for Brain Stress Systems in Addiction: Neuron
Cocaine Use Reduction with Buprenorphine (CURB: CTN-0048): Protocol Overview. - YouTube
Opioid agonists, mixed agonist-antagonists and partial agonists | Osmosis
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Psychoactives | Free Full-Text | The Role of the Dynorphin/Kappa Opioid Receptor System in the Actions of Alcohol
Pharmacy | Free Full-Text | The Potential of Methocinnamox as a Future Treatment for Opioid Use Disorder: A Narrative Review
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment - ScienceDirect
Selective kappa opioid antagonists for treatment of addiction, are we there yet? - ScienceDirect
Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System
Stress‐related neuropeptide systems as targets for treatment of alcohol addiction: A clinical perspective - Heilig - 2023 - Journal of Internal Medicine - Wiley Online Library
